por
Gallicchio, Lisa,
Helzlsouer, Kathy J.,
Chow, Wong-Ho,
Freedman, D. Michal,
Hankinson, Susan E.,
Hartge, Patricia,
Hartmuller, Virginia,
Harvey, Chinonye,
Hayes, Richard B.,
Horst, Ronald L.,
Koenig, Karen L.,
Kolonel, Laurence N.,
Laden, Francine,
McCullough, Marjorie L.,
Parisi, Dominick,
Purdue, Mark P.,
Shu, Xiao-Ou,
Snyder, Kirk,
Stolzenberg-Solomon, Rachael Z.,
Tworoger, Shelley S.,
Varanasi, Arti,
Virtamo, Jarmo,
Wilkens, Lynne R.,
Xiang, Yong-Bing,
Yu, Kai,
Zeleniuch-Jacquotte, Anne,
Zheng, Wei,
Abnet, Christian C.,
Albanes, Demetrius,
Bertrand, Kimberly,
Weinstein, Stephanie J.
Publicado 2010
“…The majority of the serum or plasma samples were assayed in a central laboratory using a direct, competitive chemiluminescence immunoassay on the DiaSorin LIAISON platform (DiaSorin, Inc.,
Stillwater, Minnesota). Masked quality control samples included serum standards from the US National Institute of Standards and Technology. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto